34 related articles for article (PubMed ID: 4672248)
1. Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.
Dluzen D; Horstink M
Endocrine; 2003 Jun; 21(1):67-75. PubMed ID: 12777705
[TBL] [Abstract][Full Text] [Related]
2. Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes.
Huey LY; Janowsky DS; Judd LL; Abrams A; Parker D; Clopton P
Psychopharmacology (Berl); 1981; 73(2):161-4. PubMed ID: 6785807
[TBL] [Abstract][Full Text] [Related]
3. Effects of ovariectomy, castration, and chronic lithium chloride treatment on stereotyped behavior in rats.
Verimer T; Arnerić SP; Long JP; Walsh BJ; Abou Zeit-Har MS
Psychopharmacology (Berl); 1981; 75(3):273-6. PubMed ID: 6275446
[TBL] [Abstract][Full Text] [Related]
4. Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
van Kammen DP; Docherty JP; Marder SR; Rosenblatt JE; Bunney WE
Psychopharmacology (Berl); 1985; 87(1):111-5. PubMed ID: 3933028
[TBL] [Abstract][Full Text] [Related]
5. Behavioral activity of rats measured by a new method based on the piezo-electric principle.
Megens AA; Voeten J; Rombouts J; Meert TF; Niemegeers CJ
Psychopharmacology (Berl); 1987; 93(3):382-8. PubMed ID: 3124168
[TBL] [Abstract][Full Text] [Related]
6. Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine.
Furukawa T; Ushizima I; Ono N
Psychopharmacologia; 1975 Jun; 42(3):243-8. PubMed ID: 1161982
[TBL] [Abstract][Full Text] [Related]
7. Experimental observations on the effect of amphepramone on the behavior, locomotion, pentretrazol seizures and electroencephalogram.
Safta L; Cuparencu B; Sirbu A; Secareanu A
Psychopharmacology (Berl); 1976 Nov; 50(2):165-9. PubMed ID: 826957
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats.
Schechter MD; Cook PG
Psychopharmacologia; 1975 May; 42(2):185-93. PubMed ID: 240181
[TBL] [Abstract][Full Text] [Related]
9. Failure of apomorphine to induce dopamine receptor hypersensitivity.
Flemenbaum A
Psychopharmacology (Berl); 1979 Apr; 62(2):175-9. PubMed ID: 111281
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment.
Van Kammen DP; Murphy DL
Psychopharmacologia; 1975 Nov; 44(3):215-24. PubMed ID: 1824
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release.
Frisk-Holmberg M; van der Kleijn E
Eur J Pharmacol; 1972 May; 18(2):139-47. PubMed ID: 4113999
[No Abstract] [Full Text] [Related]
12. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.
Rastogi RB; Lapierre YD; Singhal RL; Nair NP
Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443
[No Abstract] [Full Text] [Related]
13. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
14. Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
Lal S; Sourkes TL
Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):289-301. PubMed ID: 4672248
[No Abstract] [Full Text] [Related]
15. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
[No Abstract] [Full Text] [Related]
16. [Phenamine antagonism as a treat for experimental evaluation of neuroleptics].
Raevskiĭ KS
Farmakol Toksikol; 1973; 36(2):149-54. PubMed ID: 4151668
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
